SMAD3 and neoplasm: These miRNAs possess oncosuppressor properties: hsa-miR-16-5p targets SMAD3 in chondrocytes23,24, while hsa-miR-451 has tumor suppressor activity in many cancers25 and decreases cell chemoresistance targeting MDR1 gene26.